Atlas FDA

COHERENT OPAL PHOTOACTIVATOR

FDA premarket approval P990049/S001 · decided 2001-09-27

Approval details

PMA number
P990049
Supplement
S001
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
COHERENT OPAL PHOTOACTIVATOR
Generic name
System, laser, photodynamic therapy
Applicant
Lumenis
Date received
2000-08-16
Decision date
2001-09-27
Days to decision
407 days
Decision code
APPR
Product code
MVF
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Salt Lake City, UT
Statement
APPROVAL FOR A REVISION OF THE INDICATION FOR USE STATEMENT TO READ "FOR THE TREATMENT OF PATIENTS WITH PREDOMINANTLY CLASSIC SUBFOVEAL CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION, PATHOLOGIC MYOPIA OR PRESUMED OCULAR HISTOPLASMOSIS."

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
ACUPULSE 30/40 ST CO2 LASER SYSTEM AND ACUPULSE 40WG CO2 LASER SYSTEM (K100415)Lumenis2010-04-21
LUMENIS FAMILY OF IPL AND COMBINATION IPL/ND:YAG SYSTEMS (K030527)Lumenis2003-05-20
BCLEAR (K020591)Lumenis2002-05-16
DERMACLEAR UV-B PHOTOTHERAPY SYSTEM (K011197)Lumenis2001-12-14
LUMENIS VERSAPULSE POWERSUITE HOLMIUM (HO:YAG) AND DUAL WAVELENGTH (HO:YAG/ND:YAG) SURGICAL LASERS AND DELIVERY DEVICES (K011703)Lumenis2001-08-29